跳至主要内容
临床试验/NCT05512546
NCT05512546已完成不适用

Coil Embolization and Thromboembolic Complications in Patients With Ruptured Aneurysms

Muhammad Hassan1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年2月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
High Intensity Areas

研究概览

简要总结

Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All the patients enrolled in the study underwent MRI and Angiography.
  • Participants included in the study were confirmed on assessment, and verified for ruptured aneurysm by imaging using either computed tomography (CT) or MRI.

排除标准

  • Patients with any history of sensitivity or reaction to aspirin, or any contraindication for MRI, were excluded from the study.

研究组 & 干预措施

Aspirin Group

patients were prescribed 75 mg/day of either aspirin for 6 months

干预措施: Aspir-Low Pill (Drug)

Clopidogrel Group

75mg/day prescribed for 6 months

干预措施: Aspir-Low Pill (Drug)

结局指标

主要结局

High Intensity Areas

时间窗: 3 months

Post Procedural

次要结局

  • High Intensity Areas(at 6 months)

研究者

发起方
Muhammad Hassan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Muhammad Hassan

Registrar Neurology

Shaheed Zulfiqar Ali Bhutto Medical University

研究点 (1)

Loading locations...

相似试验

The Prevention of Thromboembolic Complications... | 临床试验